The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer

The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer

This study aimed to evaluate and compare the effects of various endocrine therapies on lipid profiles in young patients with breast cancer. A retrospective, single-center study was performed to investigate the effects of tamoxifen (TAM), tamoxifen plus ovarian function suppression (TAM+OFS), and aro...

Full description

Bibliographic Details
Main Authors:	Yi-Kun Kang, Xue Wang, Nan-Lin Hu, Jian Yue, Yi-Ran Si, Jie Ju, Song-Lin Gao, Peng Yuan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-12-01
Series:	Frontiers in Oncology
Subjects:	endocrine therapy lipid breast cancer premenopausal ovarian function suppression
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.759595/full

Similar Items

An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project
by: Giacomo Pelizzari, et al.
Published: (2018-09-01)

The impact of obesity and endocrine therapy on the prognosis of premenopausal women with hormone receptor‐positive breast cancer: A single‐institute retrospective study
by: Yukinori Ozaki, et al.
Published: (2023-02-01)

Extended adjuvant endocrine treatment for premenopausal women: A Delphi approach to guide clinical practice
by: Giuseppe Buono, et al.
Published: (2022-10-01)

Importance of evaluation of ovarian function in women with breast cancer when using endocrinotherapy
by: I. B. Kononenko, et al.
Published: (2018-07-01)

Ovarian Function Suppression With Luteinizing Hormone-Releasing Hormone Agonists for the Treatment of Hormone Receptor-Positive Early Breast Cancer in Premenopausal Women
by: Yen-Shen Lu, et al.
Published: (2021-09-01)

The role of hormonal ovarian ablation in adjuvant treatment of premenopausal breast cancer
by: Murtezani Zafir, et al.
Published: (2011-01-01)

Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico
by: Cynthia Villarreal-Garza, et al.
Published: (2021-10-01)

A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study
by: Gu Ran, et al.
Published: (2012-05-01)

A Comparitive Study to Evaluate the Role of Serum Lipid Levels in Aetiology of Carcinoma Breast
by: Vipan Kumar, et al.
Published: (2015-02-01)

Tamoxifen Effects on the lipid profile in premenopausal women with Breast cancer: A follow up study
by: Zainab A. M. Ali, et al.
Published: (2018-12-01)

ADJUVANT HORMONE THERAPY ELIGIBILITY OF PREMENOPAUSAL WOMEN WITH ER+ BREAST CANCER
by: V. F. SEMIGLAZOV, et al.
Published: (2017-06-01)

Expert consensus on clinical applications of ovarian function suppression for Chinese women with early breast cancer 2021 CACA-CBCS
by: Chinese Anti-Cancer Association, Committee of Breast Cancer Society
Published: (2022-02-01)

Clinical factors associated with patterns of endocrine therapy adherence in premenopausal breast cancer patients
by: Kirsten M. Woolpert, et al.
Published: (2024-04-01)

Appraising Adjuvant Endocrine Therapy in Hormone Receptor Positive HER2-Negative Breast Cancer—A Literature Review
by: Danilo Giffoni de Mello Morais Mata, et al.
Published: (2022-07-01)

Hot flushes and sweating, sleep problems, joint and muscular discomfort, and physical and mental exhaustion in breast cancer survivors during the first 24 months of tamoxifen therapy: a prospective observational study
by: Sumi Sung, et al.
Published: (2022-08-01)

Tactics for minimizing risk of increasing estradiol against the background of aromatase inhibitors in combination with gonadotropin releasing hormone agonists in adjuvant therapy for breast cancer in premenopausal patients. Pilot study results
by: I. B. Kononenko, et al.
Published: (2018-11-01)

Reproductive risk factors associated with breast cancer in young women by molecular subtype
by: Kathryn J. Ruddy, et al.
Published: (2022-12-01)

Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy
by: Ann H. Partridge, et al.
Published: (2021-10-01)

Effectiveness of a 6-Month 22.5-mg Leuprolide Acetate Depot Formulation With Tamoxifen for Postoperative Premenopausal Estrogen Suppression in Hormone Receptor-Positive Breast Cancer
by: Zhen-Yu Wu, et al.
Published: (2021-04-01)

Lipid changes during endocrine therapy in early-stage breast cancer patients: A real-world study
by: Yuechong Li, et al.
Published: (2024-01-01)

Endocrine issues and premenopausal breast cancer
by: Mara Carsote, et al.
Published: (2021-12-01)

Association Between Bone Mineral Density and Lipid Profile in Chinese Women
by: Zhang Q, et al.
Published: (2020-09-01)

Inflammatory biomarkers and risk of breast cancer among young women in Latin America: a case-control study
by: Emma Fontvieille, et al.
Published: (2022-08-01)

Encapsulated Allografts Preclude Host Sensitization and Promote Ovarian Endocrine Function in Ovariectomized Young Rhesus Monkeys and Sensitized Mice
by: James R. Day, et al.
Published: (2023-05-01)

Postoperative chemotherapy had no prognostic effect on early‐staged young ovarian cancer with unilateral resection
by: Xiaofei Zhang, et al.
Published: (2018-11-01)

Lipidome of mammographic breast density in premenopausal women
by: Kayla R. Getz, et al.
Published: (2023-10-01)

Hyperprolactinaemia is common in Chinese premenopausal women with breast diseases
by: Jiang Zhu, et al.
Published: (2023-02-01)

Adherence to endocrine therapy among Chinese patients with breast cancer: current status and recommendations for improvement
by: Gao P, et al.
Published: (2018-05-01)

Association of overweight and obesity with breast cancer during premenopausal period in Asia: A meta-analysis
by: Ricvan Dana Nindrea, et al.
Published: (2019-01-01)

A Study to Evaluate Risk of Ovarian Malignancy Algorithm (ROMA) in Patients with Ovarian Masses
by: Asna Aafreen, et al.
Published: (2022-07-01)

Ovarian cycle stage critically affects 21-gene recurrence scores in Mmtv-Pymt mouse mammary tumours
by: Sarah M. Bernhardt, et al.
Published: (2021-06-01)

Effect of ribociclib on productivity losses due to breast cancer in young women in Brazil
by: Anna Maria Buehler, et al.
Published: (2022-12-01)

Dyslipidaemia in endocrine disorders
by: Kalyani Sridharan, et al.
Published: (2024-03-01)

Novel strategies to improve the endocrine therapy of breast cancer
by: Aurelio Bartolome Castrellon
Published: (2017-05-01)

Project profile: a multicenter study on breast cancer in young women in Latin America (PRECAMA study)
by: Isabelle Romieu, et al.
Published: (2019-10-01)

Expert consensus on clinical applications of ovarian function suppression for Chinese women with early breast cancer (2024 edition)
by: Committee of Breast Cancer Society, China Anti-Cancer Association
Published: (2024-03-01)

Comparative Study of Lipid Profile in Premenopausal and Postmenopausal Women
by: Seema Takras1, Sudha Karadkhedkar1 and Shreechakradhar Mungal1
Published: (2021-08-01)

The Association Between Body Mass Index, Lipid Profile and Serum Estradiol Levels in a Sample of Iraqi Diabetic Premenopausal Women
by: Mahmood Shakir Al-Zaidi, et al.
Published: (2011-07-01)

How to Protect Ovarian Function before and during Chemotherapy?
by: Luca Arecco, et al.
Published: (2021-09-01)

Adolescent and early adulthood inflammation-associated dietary patterns in relation to premenopausal mammographic density
by: Nichole A. Garzia, et al.
Published: (2021-07-01)